PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Shareholder Meeting Results - Directors Elected and Accounting Firm Approved
Announces New Research Supporting Integration and Use of Pedmark® at the 2026 ASCO Annual Meeting
Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Director Retirement - Rostislav Raykov Steps Down from Board
Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
Investigator-Sponsored Study to be Conducted by University of Arizona Cancer Center
Financial Results, Press Release
Announces Settlement Agreement Resolving PEDMARK Patent Litigation
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload